AGEN MEXC RealStocks
Own real AGEN shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 05:33:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Agenus Inc. (AGEN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $6.71, with a market capitalization of $304.51M and a P/E ratio of 10.34. Over the past 52 weeks, its price has ranged from $2.71 to $10.31. This page covers its latest market performance, valuation, price trends and company information.
$304.51M | |
$6.97 | |
$7.15 | |
$6.51 | |
$6.87 | |
385.36K | |
960.10K | |
10.34 | |
$10.31 | |
$2.71 | |
-- | |
-- |
Agenus Inc. (AGEN) last closed at $6.71 as of 2026-11-14 00:31:00, down 2.18% ($0.15) from the previous close of $6.87.
During the latest regular trading session, AGEN traded between $6.51 and $7.15, with a volume of 385.36K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Agenus Inc. (AGEN) moved from $6.44 to $6.71, representing a gain of 4.19% ($0.27).
The stock traded between $6.11 and $7.65 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 733.62 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 52.6%
AGEN is currently trading at $6.71, placing it 52.6% of the way from its 52-week low of $2.71 to its 52-week high of $10.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 81 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Agenus Inc. (AGEN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AGEN, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between AGEN shares and USD.
AGEN Shares to USD
1.00 AGEN shares = 6.71 USD
Calculations are estimates based on the latest available price and are for reference only.